Related Experiment Video

Updated: May 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring

Mary A Zimmerman1, Nur-Taz Rahman, Dafeng Yang

  • 1Department of Biochemistry and Molecular Biology, Georgia Health Sciences University, Augusta, Georgia 30912, USA.

Cancer Research
|July 19, 2012
PubMed

Insights

The phosphorylation status of STAT1 (Signal Transducer and Activator of Transcription 1) determines its role in soft tissue sarcoma. Unphosphorylated STAT1 promotes tumor growth and immune escape, while phosphorylated STAT1 acts as a tumor suppressor.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Signal Transducer and Activator of Transcription 1 (STAT1) is crucial for IFN-γ signaling and cancer immunosurveillance.
  • STAT1 exists in phosphorylated (pSTAT1) and unphosphorylated (uSTAT1) forms, with their distinct roles in human cancers, including soft tissue sarcoma (STS), being unclear.
  • STAT1 overexpression is observed in certain human cancers, necessitating a deeper understanding of its functional dichotomy.

Purpose of the Study:

  • To investigate the distinct roles of pSTAT1 and uSTAT1 in soft tissue sarcoma (STS) progression and metastasis.
  • To elucidate the regulatory mechanisms controlling STAT1 phosphorylation status in STS.
  • To determine the prognostic significance of pSTAT1 and uSTAT1 levels in human STS specimens.

Main Methods:

  • Utilized a murine model of soft tissue sarcoma (STS) to study the effects of Interferon Regulatory Factor 8 (IRF8) disruption on STAT1.
  • Analyzed IRF8 gene promoter methylation in human STS samples.
  • Correlated pSTAT1 and uSTAT1 levels with disease-specific survival (DSS) in 123 human STS specimens.
  • Employed RNA interference (RNAi) to silence STAT1 in STS cells and assessed apoptosis-related gene expression and sensitivity to Fas-mediated apoptosis.

Main Results:

  • Disruption of IRF8 in a murine STS model led to decreased pSTAT1, increased uSTAT1, and enhanced metastatic potential.
  • Hypermethylation of the IRF8 gene promoter was frequent in human STS.
  • High uSTAT1 levels correlated with reduced DSS, while high pSTAT1 levels correlated with increased DSS in human STS.
  • Mechanistically, IRF8 suppresses STAT1 transcription, and STAT1 silencing increased sensitivity to Fas-mediated apoptosis.

Conclusions:

  • The phosphorylation state of STAT1 dictates its function in STS: pSTAT1 acts as a tumor suppressor, whereas uSTAT1 promotes tumor growth.
  • uSTAT1 promotes immune escape by increasing resistance to Fas-mediated apoptosis.
  • IRF8 acts as a tumor suppressor by inhibiting STAT1 transcription, and its epigenetic silencing contributes to STS progression.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...